{"nct_id":"NCT05111626","title":"Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2022-03-14","start_date_type":"ACTUAL","primary_completion_date":"2026-01-29","primary_completion_date_type":"ESTIMATED","completion_date":"2027-01-29","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AMGN"]}